Gossamer Bio, Inc.

1
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US38341P1021
USD
3.32
0.33 (11.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Gossamer Bio, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-55.00
-179.00
-229.00
-234.00
-243.00
-180.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
39.00
-14.00
-4.00
0.00
-3.00
10.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-3.00
-159.00
-187.00
-188.00
-176.00
-144.00
Cash Flow from Investing Activities
29.00
-110.00
-1.00
-117.00
215.00
-147.00
Cash Flow from Financing Activities
-11.00
190.00
117.00
3.00
312.00
321.00
Net Cash Inflow / Outflow
13.00
-79.00
-71.00
-303.00
351.00
29.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Gossamer Bio, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-55.635
-182.629
127.00
69.54%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
39.46
29.742
10.00
32.67%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-3.468
-148.803
145.00
97.67%
Cash Flow from Investing Activities
29.023
82.217
-53.00
-64.70%
Cash Flow from Financing Activities
-11.488
62.881
-73.00
-118.27%
Net Cash Inflow / Outflow
13.965
-3.705
16.00
476.92%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.102
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 97.82% vs 14.90% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-3.47
-159.16
97.82%